Citations (45)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Pauli V. Luoma. (2007) Cytochrome P450 — physiological key factor against cholesterol accumulation and the atherosclerotic vascular process. Annals of Medicine 39:5, pages 359-370.
Read now
Read now
P. V. Luoma, E. A. Sotaniemi & A. J. Arranto. (1983) Serum LDL cholesterol, the LDL/HDL cholesterol ratio and liver microsomal enzyme induction evaluated by antipyrine kinetics. Scandinavian Journal of Clinical and Laboratory Investigation 43:8, pages 671-675.
Read now
Read now
Paul N. Durrington & J. Paul Miller. (1982) High-Density Lipoprotein Cholesterol: Methods and Clinical Significance. CRC Critical Reviews in Clinical Laboratory Sciences 18:1, pages 31-78.
Read now
Read now
P. V. Luoma, E. A. Sotaniemi & C. Ehnholm. (1980) Low High-Density Lipoprotein and Reduced Antipyrine Metabolism in Members of a Family with Polycystic Liver Disease. Scandinavian Journal of Gastroenterology 15:7, pages 869-873.
Read now
Read now
Articles from other publishers (41)
Janne Hukkanen & Jukka Hakkola. (2020) PXR and 4β-Hydroxycholesterol Axis and the Components of Metabolic Syndrome. Cells 9:11, pages 2445.
Crossref
Crossref
Tuire Salonurmi, Heba Nabil, Justiina Ronkainen, Tuulia Hyötyläinen, Heidi Hautajärvi, Markku J. Savolainen, Ari Tolonen, Matej Orešič, Päivi Känsäkoski, Jaana Rysä, Jukka Hakkola & Janne Hukkanen. (2020) 4β-Hydroxycholesterol Signals From the Liver to Regulate Peripheral Cholesterol Transporters. Frontiers in Pharmacology 11.
Crossref
Crossref
Miriam Hampel, Julian Blasco, Massimiliano Babbucci, Serena Ferraresso, Luca Bargelloni & Massimo Milan. (2017) Transcriptome analysis of the brain of the sea bream (Sparus aurata) after exposure to human pharmaceuticals at realistic environmental concentrations. Marine Environmental Research 129, pages 36-45.
Crossref
Crossref
Eva Choong, Andrea Polari, Rigobert Hervais Kamdem, Nicola Gervasoni, Caesar Spisla, Eveline Jaquenoud Sirot, Graziella Giacometti Bickel, Guido Bondolfi, Philippe Conus & Chin B. Eap. (2013) Pharmacogenetic Study on Risperidone Long-Acting Injection. Journal of Clinical Psychopharmacology 33:3, pages 289-298.
Crossref
Crossref
Kanitpong Phabphal, Alan Geater, Kitti Limapichart, Pornchai Sathirapanya & Suwanna Setthawatcharawanich. (2013) Role of CYP2C9 polymorphism in phenytoin-related metabolic abnormalities and subclinical atherosclerosis in young adult epileptic patients. Seizure 22:2, pages 103-108.
Crossref
Crossref
Hirokazu Matsuda, Yukio Taniguchi & Hiroaki Iwaisaki. (2012) QTL/microarray approach using pathway information. Algorithms for Molecular Biology 7:1.
Crossref
Crossref
Torbjörn Lindström, Stergios Kechagias, Martin Carlsson & Fredrik H. Nystrom. (2012) Transient Increase in HDL‐Cholesterol During Weight Gain by Hyperalimentation in Healthy Subjects. Obesity 19:4, pages 812-817.
Crossref
Crossref
P. -V. Lunoma. (2009) Cytochrome P450 et activation génétique — de la pharmacologie à l’élimination du cholestérol et à la régression de l’athéroscléroseCytochrome P450 and gene activation — from pharmacology to cholesterol elimination and regression of atherosclerosis. Bio tribune magazine 30:1, pages 15-24.
Crossref
Crossref
Pauli V. Luoma. (2008) Cytochrome P450 and gene activation—from pharmacology to cholesterol elimination and regression of atherosclerosis. European Journal of Clinical Pharmacology 64:9, pages 841-850.
Crossref
Crossref
M. Strolin Benedetti, B. Ruty & E. Baltes. (2005) Induction of endogenous pathways by antiepileptics and clinical implications. Fundamental and Clinical Pharmacology 19:5, pages 511-529.
Crossref
Crossref
Gail D. Anderson. (2004) Pharmacogenetics and enzyme induction/inhibition properties of antiepileptic drugs. Neurology 63:10_suppl_4.
Crossref
Crossref
María J. Tutor-Crespo, Jesús Hermida & J. Carlos Tutor. (2004) Possible Induction of Cholinesterase in Epileptic Patients Treated With Anticonvulsant Drugs: Relationship With Lipoprotein Levels. The Journal of Clinical Pharmacology 44:9, pages 974-980.
Crossref
Crossref
MARTHA J. MORRELL. 2004. Principles of Gender-Specific Medicine. Principles of Gender-Specific Medicine
116
128
.
Martha J. Morrell. (2003) Reproductive and Metabolic Disorders in Women with Epilepsy. Epilepsia 44, pages 11-20.
Crossref
Crossref
Susanne Brämswig, Anja Kerksiek, Thomas Sudhop, Claus Luers, Klaus Von Bergmann & Heiner K. Berthold. (2002) Carbamazepine increases atherogenic lipoproteins: mechanism of action in male adults. American Journal of Physiology-Heart and Circulatory Physiology 282:2, pages H704-H716.
Crossref
Crossref
James W. McAuley & Gail D. Anderson. (2002) Treatment of Epilepsy in Women of Reproductive Age. Clinical Pharmacokinetics 41:8, pages 559-579.
Crossref
Crossref
Sadiye Demircioğlu, Alper Soylu & Eray Dirik. (2000) Carbamazepine and valproic acid: effects on the serum lipids and liver functions in children. Pediatric Neurology 23:2, pages 142-146.
Crossref
Crossref
MN Nanjee, H Verhagen, G van Poppel, CJ Rompelberg, PJ van Bladeren & NE Miller. (1996) Do dietary phytochemicals with cytochrome P-450 enzyme-inducing activity increase high-density-lipoprotein concentrations in humans?. The American Journal of Clinical Nutrition 64:5, pages 706-711.
Crossref
Crossref
Michael MillerRachel G. BurganLaura OsterlundJere P. SegrestDavid W. Garber. (1995) A Prospective, Randomized Trial of Phenytoin in Nonepileptic Subjects With Reduced HDL Cholesterol. Arteriosclerosis, Thrombosis, and Vascular Biology 15:12, pages 2151-2156.
Crossref
Crossref
A. F. Godinho & M. A. Silva. (2009) Effects of Misoprostol on Circulating HDL‐Cholesterol, Total Cholesterol, Triglycerides and their Relationship with Hepatic Microsomal Function. Pharmacology & Toxicology 77:4, pages 255-258.
Crossref
Crossref
Chris Goerdt, Mary Keith & Hanna Bloomfield Rubins. (2013) Effects of Phenytoin on Plasma High‐Density Lipoprotein Cholesterol Levels in Men with Low Levels of High‐Density Lipoprotein Cholesterol. The Journal of Clinical Pharmacology 35:8, pages 767-775.
Crossref
Crossref
Jouko I. T. Isojärvi, Arto J. Pakarinen, Arja Rautio, Olavi Pelkonen & Vilho V. Myllylä. (2005) Liver Enzyme Induction and Serum Lipid Levels After Replacement of Carbamazepine with Oxcarbazepine. Epilepsia 35:6, pages 1217-1220.
Crossref
Crossref
James M. McKenney, Kathleen S. Petrizzi, Geneva C. Briggs & Jackson T. WrightJr.Jr.. (2012) The Effect of Low‐Dose Phenytoin on High‐Density Lipoprotein Cholesterol. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 12:3, pages 183-188.
Crossref
Crossref
Toshihito Suzuki, Junzo Koizumi, Takashi Moroji, Hiroyasu Shiraishi, Takafumi Hori, Atsuomi Baba, Nobutoshi Kawai & Koji Tada. (1992) Effects of long-term anticonvulsant therapy on copper, zinc, and magnesium in hair and serum of epileptics. Biological Psychiatry 31:6, pages 571-581.
Crossref
Crossref
Susan E. Hahn & David M. Goldberg. (1992) Modulation of lipoprotein production in hep G2 cells by fenofibrate and clofibrate. Biochemical Pharmacology 43:3, pages 625-633.
Crossref
Crossref
Elena Pita Calandre, Blanca Sinués Porta & Dolores García de la Calzada. (2005) The Effect of Chronic Phenytoin Treatment on Serum Lipid Profile in Adult Epileptic Patients. Epilepsia 33:1, pages 154-157.
Crossref
Crossref
E. P. Calandre, C. Rodriguez-Lopez, A. Blazquez & D. Cano. (1991) Serum lipids, lipoproteins and apolipoproteins A and B in epileptic patients treated with valproic acid, carbamazepine or phenobarbital. Acta Neurologica Scandinavica 83:4, pages 250-253.
Crossref
Crossref
CH Cho, SM Chen, CW Ogle & TK Young. (1989) Effects of zinc and cholesterol/choleate on serum lipoproteins and the liver in rats. Life Sciences 44:25, pages 1929-1936.
Crossref
Crossref
P. V. Luoma. (2009) Mlicrosomal Enzyme Induction, Lipoproteins and Atherosclerosis. Pharmacology & Toxicology 62:5, pages 243-249.
Crossref
Crossref
P. V. Luoma, J. E. Heikkinen, C. Ehnholm & P. R. Yl�stalo. (1987) One year study of effects of an oestrogen-dominant oral contraceptive on serum high-density lipoprotein cholesterol, apolipoproteins A-I and A-II and hepatic microsomal function. European Journal of Clinical Pharmacology 31:5, pages 563-567.
Crossref
Crossref
Charles J. Glueck. (1985) Nonpharmacologic and pharmacologic alteration of high-density lipoprotein cholesterol: Therapeutic approaches to prevention of atherosclerosis. American Heart Journal 110:5, pages 1107-1115.
Crossref
Crossref
P. V. Luoma, H. Korpela, E. A. Sotaniemi & J. Kumpulainen. (1985) Serum selenium, glutathione peroxidase, lipids, and human liver microsomal enzyme activity. Biological Trace Element Research 8:2, pages 113-121.
Crossref
Crossref
P. V. LUOMA, M. J. SAVOLAINEN, E. A. SOTANIEMI, A. J. ARRANTO & R. O. PELKONEN. (2009) Plasma HDL Cholesterol and Blood Glucose in Non‐insulin‐dependent Diabetics Related to Liver Lipids and Microsomal Enzyme Activity. Acta Medica Scandinavica 217:5, pages 473-479.
Crossref
Crossref
P. V. Luoma, E. A. Sotaniemi, R. O. Pelkonen & H. I. Pirttiaho. (1985) Serum low-density lipoprotein and high-density lipoprotein cholesterol, and liver size in subjects on drugs inducing hepatic microsomal enzymes. European Journal of Clinical Pharmacology 28:6, pages 615-618.
Crossref
Crossref
Russell M. Dixon, Ernest C. Borden, Nancy L. Keim, Susan Anderson, Terry L. Spennetta, Douglas C. Tormey & Earl Shrago. (1984) Decreases in serum high-density-lipoprotein cholesterol and total cholesterol resulting from naturally produced and recombinant DNA-derived leukocyte interferons. Metabolism 33:5, pages 400-404.
Crossref
Crossref
S. Dessì, B. Batetta, E. Laconi, C. Ennas & P. Pani. (1984) Hepatic cholesterol in lead nitrate induced liver hyperplasia. Chemico-Biological Interactions 48:3, pages 271-279.
Crossref
Crossref
P.V. Luoma, E.A. Sotaniemi & R.O. Pelkonen. (1984) ALCOHOL, HDL CHOLESTEROL, AND LIVER MICROSOMAL INDUCTION. The Lancet 323:8367, pages 47.
Crossref
Crossref
P. V. LUOMA, M. J. SAVOLAINEN, E. A. SOTANIEMI, R. O. PELKONEN, A. J. ARRANTO & C. EHNHOLM. (2009) Plasma High‐Density Lipoproteins and Liver Lipids and Proteins in Man. Acta Medica Scandinavica 214:2, pages 103-109.
Crossref
Crossref
P.V. Luoma, E.A. Sotaniemi, R.O. Pelkonen, M.J. Savolainen & C. Ehnholm. (1982) INDUCTION AND LIPOPROTEINS. The Lancet 319:8272, pages 625.
Crossref
Crossref
Jack Ferlinz. (1982) DOES PLACEBO LOWER BLOOD PRESSURE?. The Lancet 319:8272, pages 624-625.
Crossref
Crossref
C Ehnholm, K Aho, J K Huttunen, E Kostiainen, K Mattila, J Pakkarainen & K Cantell. (1982) Effect of interferon on plasma lipoproteins and on the activity of postheparin plasma lipases.. Arteriosclerosis: An Official Journal of the American Heart Association, Inc. 2:1, pages 68-73.
Crossref
Crossref